Back to results
US 2011/0178043 A1Published application
Inhibitors of the mevalonate pathway of streptococcus pneumoniae
AssigneeNorthwestern University
InventorsRichard B. Silverman, Takashi Kudoh
Life of this patent
Estimating the term…
Abstract
Compounds and related methods as can be used for selective mevalonate pathway inhibitors.
Claims25
A mevalonate pathway inhibitor compound of a formula
- wherein R1 is selected from C2 to about C6 alkyl, C2 to about C6 substituted alkyl, C2 to about C6 alkenyl, C2 to about C6 substituted alkenyl, C2 to about C6 alkynyl, C2 to about C6 substituted alkynyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl moieties;
- and R2 and R2′ are independently selected from H, monophosphate and diphosphate moieties;
- and salts, esters, hydrates and solvates thereof.
A mevalonate pathway inhibitor compound of a formula
- wherein R1 is selected from C2 to about C6 alkyl, C2 to about C6 substituted alkyl, C2 to about C6 alkenyl, C2 to about C6 substituted alkenyl, C2 to about C6 alkynyl, and C2 to about C6 substituted alkynyl moieties;
- and salts, esters, hydrates and solvates thereof.
A method of treating Streptococcus pneumoniae comprising contacting Streptococcus pneumoniae with an effective amount of a compound of formula
- wherein R1 is selected from C2 to about C6 alkyl, C2 to about C6 substituted alkyl, C2 to about C6 alkenyl, C2 to about C6 substituted alkenyl, C2 to about C6 alkynyl, and C2 to about C6 substituted alkynyl moieties;
- and salts, esters, hydrates and solvates thereof.
A method of using a C-3 substituent of a mevalonate analog compound to affect an enzyme in a mevalonate biosynthetic pathway, said method comprising contacting a mevalonate pathway enzyme with an effective amount of a compound of a formula
- wherein R1 is selected from C2 to about C6 alkyl, C2 to about C6 substituted alkyl, C2 to about C6 alkenyl, C2 to about C6 substituted alkenyl, C2 to about C6 alkynyl, C2 to about C6 substituted alkynyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl moieties;
- and R2 and R2′ are independently selected from H, monophosphate and diphosphate moieties;
- and salts, esters, hydrates and solvates thereof.
Dependencies are inferred from the claim text.